Informatie:
Fout:
ID
13469
Beschrijving
Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Trefwoorden
Versies (5)
- 04-03-15 04-03-15 -
- 09-03-15 09-03-15 -
- 22-04-15 22-04-15 -
- 08-12-15 08-12-15 -
- 11-02-16 11-02-16 -
Geüploaded op
11 februari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Evaluation AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)
Evaluation AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Similar models
Evaluation AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
CL Item
Induction I (1)
C3179010 (UMLS CUI-1)
CL Item
Induction II (optional) (2)
C3179010 (UMLS CUI-1)
CL Item
Consolidation I (3)
C3179017 (UMLS CUI-1)
CL Item
Consolidation II (4)
C3179017 (UMLS CUI-1)
CL Item
Consolidation III (5)
C3179017 (UMLS CUI-1)
CL Item
Consolidation IV (6)
C3179017 (UMLS CUI-1)
CL Item
Maintenance (7)
C0481504 (UMLS CUI-1)
CL Item
Follow-up (8)
C1522577 (UMLS CUI-1)
Item
If in Maintenance: Month
integer
C0481504 (UMLS CUI [1,1])
C0439231 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
CL Item
after 3 Months (3)
C1522577 (UMLS CUI-1)
C1442461 (UMLS CUI-2)
C1442461 (UMLS CUI-2)
CL Item
after 6 Months (6)
C1522577 (UMLS CUI-1)
C0589124 (UMLS CUI-2)
C0589124 (UMLS CUI-2)
CL Item
after 9 Months (9)
C1522577 (UMLS CUI-1)
CL Item
after 12 Months (12)
C1522577 (UMLS CUI-1)
Follow up number
Item
If Follow-up: consecutive Follow-up number
integer
C1522577 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,2])
Status of patient
Item
Is the patient alive?
boolean
C1148433 (UMLS CUI [1])
Date of last information/death
Item
Date of last information/death
date
C0805839 (UMLS CUI-1)
CL Item
Leukemia (1)
C0023418 (UMLS CUI-1)
CL Item
Infection (2)
C0009450 (UMLS CUI-1)
CL Item
Bleeding (3)
C0019080 (UMLS CUI-1)
CL Item
Secondary illness (4)
C0277555 (UMLS CUI-1)
CL Item
Other (5)
C0205394 (UMLS CUI-1)
CL Item
Unknown (6)
C0439673 (UMLS CUI-1)
Specifiy if Cause of death = 2,4,5
Item
Specifiy if Cause of death = 2,4,5
text
C1521902 (UMLS CUI [1])
Item Group
Response after Induction Cycles or Consolidation or Maintenance or during Follow-up
Date of evaluation
Item
Date of evaluation
date
C2985720 (UMLS CUI [1])
CL Item
CR (1)
C0677874 (UMLS CUI-1)
CL Item
CRi (2)
C3538993 (UMLS CUI-1)
CL Item
PR (3)
C1521726 (UMLS CUI-1)
CL Item
RD (4)
C3844738 (UMLS CUI-1)
CL Item
PD (5)
C1335499 (UMLS CUI-1)
CL Item
ED (6)
CL Item
HD (7)
Extramedullary Manifestatation
Item
Extramedullary Manifestatation
boolean
C1868812 (UMLS CUI [1])
Extramedullary Manifestatation location
Item
Please specify Extramedullary Manifestation
text
C1521902 (UMLS CUI [1])
Item Group
Evaluation based on on following examinations
Bone marrow evaluation done
Item
Bone marrow evaluation done (If yes specify on CRF "Bone marrow Evaluation"
boolean
C0005953 (UMLS CUI [1])
Blood count evaluation done
Item
Blood count evaluation done? (If yes specify on CRF "Blood Count Evaluation"
boolean
C0005771 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)
Geen commentaren